Tetramethylpyrazine reverses high-glucose induced hypoxic effects by negatively regulating HIF-1α induced BNIP3 expression to ameliorate H9c2 cardiomyoblast apoptosis

Diabetic patients are highly vulnerable to hypoxic injury, which is associated with hypoxia induced BNIP3 expression that subsequently activate apoptosis. Our previous research show that Tetramethylpyrazine (TMP), a food flavoring agent, represses the hypoxia induced BNIP3 expression attenuate myoca...

Full description

Saved in:
Bibliographic Details
Published inNutrition & metabolism Vol. 17; no. 1; p. 12
Main Authors Liu, Shih-Ping, Shibu, Marthandam Asokan, Tsai, Fuu-Jen, Hsu, Yuan-Man, Tsai, Chang-Hai, Chung, Jing-Gung, Yang, Jai-Sing, Tang, Chih-Hsin, Wang, Shulin, Li, Qiaowen, Huang, Chih-Yang
Format Journal Article
LanguageEnglish
Published England BioMed Central 31.01.2020
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Diabetic patients are highly vulnerable to hypoxic injury, which is associated with hypoxia induced BNIP3 expression that subsequently activate apoptosis. Our previous research show that Tetramethylpyrazine (TMP), a food flavoring agent, represses the hypoxia induced BNIP3 expression attenuate myocardial apoptosis. In this study, we evaluate the effect of TMP to provide protection against hypoxia aggravated high-glucose associated cellular apoptosis. The cytoprotective effect of TMP against high glucose induced cellular damages was determined on embryo derived H9c2 cardiomyoblast cells that were subjected to 5% hypoxia for 24 h and subjected to different duration of 33 mM high glucose challenge. Further, the involvement of HIF-1α and BNIP3 in cellular damage and the mechanism of protection of TMP were determined by overexpression and silencing HIF-1α and BNIP3 protein expression. The results show that hypoxic effects on cell viability aggravates with high glucose challenge and this augmentative effect is mediated through BNIP3 in H9c2 cardiomyoblast cells. However, TMP administration effectively reversed the augmented HIF-1α levels and BNIP3 elevation. TMP improved the survival of H9c2 cells and effectively suppressed apoptosis in H9c2 cells. Further comparison on the effects of TMP on H9c2 cells challenged with high glucose and those challenged with hypoxia show that TMP precisely regulated the hypoxic intensified apoptotic effects in high-glucose condition. The results clearly show that flavoring agent-TMP attenuates cytotoxicity amplified by hypoxia challenge in high glucose condition by destabilizing HIF-1α.
AbstractList Background Diabetic patients are highly vulnerable to hypoxic injury, which is associated with hypoxia induced BNIP3 expression that subsequently activate apoptosis. Our previous research show that Tetramethylpyrazine (TMP), a food flavoring agent, represses the hypoxia induced BNIP3 expression attenuate myocardial apoptosis. In this study, we evaluate the effect of TMP to provide protection against hypoxia aggravated high-glucose associated cellular apoptosis. Methods The cytoprotective effect of TMP against high glucose induced cellular damages was determined on embryo derived H9c2 cardiomyoblast cells that were subjected to 5% hypoxia for 24 h and subjected to different duration of 33 mM high glucose challenge. Further, the involvement of HIF-1α and BNIP3 in cellular damage and the mechanism of protection of TMP were determined by overexpression and silencing HIF-1α and BNIP3 protein expression. Results The results show that hypoxic effects on cell viability aggravates with high glucose challenge and this augmentative effect is mediated through BNIP3 in H9c2 cardiomyoblast cells. However, TMP administration effectively reversed the augmented HIF-1α levels and BNIP3 elevation. TMP improved the survival of H9c2 cells and effectively suppressed apoptosis in H9c2 cells. Further comparison on the effects of TMP on H9c2 cells challenged with high glucose and those challenged with hypoxia show that TMP precisely regulated the hypoxic intensified apoptotic effects in high-glucose condition. Conclusion The results clearly show that flavoring agent-TMP attenuates cytotoxicity amplified by hypoxia challenge in high glucose condition by destabilizing HIF-1α.
Diabetic patients are highly vulnerable to hypoxic injury, which is associated with hypoxia induced BNIP3 expression that subsequently activate apoptosis. Our previous research show that Tetramethylpyrazine (TMP), a food flavoring agent, represses the hypoxia induced BNIP3 expression attenuate myocardial apoptosis. In this study, we evaluate the effect of TMP to provide protection against hypoxia aggravated high-glucose associated cellular apoptosis. The cytoprotective effect of TMP against high glucose induced cellular damages was determined on embryo derived H9c2 cardiomyoblast cells that were subjected to 5% hypoxia for 24 h and subjected to different duration of 33 mM high glucose challenge. Further, the involvement of HIF-1α and BNIP3 in cellular damage and the mechanism of protection of TMP were determined by overexpression and silencing HIF-1α and BNIP3 protein expression. The results show that hypoxic effects on cell viability aggravates with high glucose challenge and this augmentative effect is mediated through BNIP3 in H9c2 cardiomyoblast cells. However, TMP administration effectively reversed the augmented HIF-1α levels and BNIP3 elevation. TMP improved the survival of H9c2 cells and effectively suppressed apoptosis in H9c2 cells. Further comparison on the effects of TMP on H9c2 cells challenged with high glucose and those challenged with hypoxia show that TMP precisely regulated the hypoxic intensified apoptotic effects in high-glucose condition. The results clearly show that flavoring agent-TMP attenuates cytotoxicity amplified by hypoxia challenge in high glucose condition by destabilizing HIF-1α.
Abstract Background Diabetic patients are highly vulnerable to hypoxic injury, which is associated with hypoxia induced BNIP3 expression that subsequently activate apoptosis. Our previous research show that Tetramethylpyrazine (TMP), a food flavoring agent, represses the hypoxia induced BNIP3 expression attenuate myocardial apoptosis. In this study, we evaluate the effect of TMP to provide protection against hypoxia aggravated high-glucose associated cellular apoptosis. Methods The cytoprotective effect of TMP against high glucose induced cellular damages was determined on embryo derived H9c2 cardiomyoblast cells that were subjected to 5% hypoxia for 24 h and subjected to different duration of 33 mM high glucose challenge. Further, the involvement of HIF-1α and BNIP3 in cellular damage and the mechanism of protection of TMP were determined by overexpression and silencing HIF-1α and BNIP3 protein expression. Results The results show that hypoxic effects on cell viability aggravates with high glucose challenge and this augmentative effect is mediated through BNIP3 in H9c2 cardiomyoblast cells. However, TMP administration effectively reversed the augmented HIF-1α levels and BNIP3 elevation. TMP improved the survival of H9c2 cells and effectively suppressed apoptosis in H9c2 cells. Further comparison on the effects of TMP on H9c2 cells challenged with high glucose and those challenged with hypoxia show that TMP precisely regulated the hypoxic intensified apoptotic effects in high-glucose condition. Conclusion The results clearly show that flavoring agent-TMP attenuates cytotoxicity amplified by hypoxia challenge in high glucose condition by destabilizing HIF-1α.
Diabetic patients are highly vulnerable to hypoxic injury, which is associated with hypoxia induced BNIP3 expression that subsequently activate apoptosis. Our previous research show that Tetramethylpyrazine (TMP), a food flavoring agent, represses the hypoxia induced BNIP3 expression attenuate myocardial apoptosis. In this study, we evaluate the effect of TMP to provide protection against hypoxia aggravated high-glucose associated cellular apoptosis.BACKGROUNDDiabetic patients are highly vulnerable to hypoxic injury, which is associated with hypoxia induced BNIP3 expression that subsequently activate apoptosis. Our previous research show that Tetramethylpyrazine (TMP), a food flavoring agent, represses the hypoxia induced BNIP3 expression attenuate myocardial apoptosis. In this study, we evaluate the effect of TMP to provide protection against hypoxia aggravated high-glucose associated cellular apoptosis.The cytoprotective effect of TMP against high glucose induced cellular damages was determined on embryo derived H9c2 cardiomyoblast cells that were subjected to 5% hypoxia for 24 h and subjected to different duration of 33 mM high glucose challenge. Further, the involvement of HIF-1α and BNIP3 in cellular damage and the mechanism of protection of TMP were determined by overexpression and silencing HIF-1α and BNIP3 protein expression.METHODSThe cytoprotective effect of TMP against high glucose induced cellular damages was determined on embryo derived H9c2 cardiomyoblast cells that were subjected to 5% hypoxia for 24 h and subjected to different duration of 33 mM high glucose challenge. Further, the involvement of HIF-1α and BNIP3 in cellular damage and the mechanism of protection of TMP were determined by overexpression and silencing HIF-1α and BNIP3 protein expression.The results show that hypoxic effects on cell viability aggravates with high glucose challenge and this augmentative effect is mediated through BNIP3 in H9c2 cardiomyoblast cells. However, TMP administration effectively reversed the augmented HIF-1α levels and BNIP3 elevation. TMP improved the survival of H9c2 cells and effectively suppressed apoptosis in H9c2 cells. Further comparison on the effects of TMP on H9c2 cells challenged with high glucose and those challenged with hypoxia show that TMP precisely regulated the hypoxic intensified apoptotic effects in high-glucose condition.RESULTSThe results show that hypoxic effects on cell viability aggravates with high glucose challenge and this augmentative effect is mediated through BNIP3 in H9c2 cardiomyoblast cells. However, TMP administration effectively reversed the augmented HIF-1α levels and BNIP3 elevation. TMP improved the survival of H9c2 cells and effectively suppressed apoptosis in H9c2 cells. Further comparison on the effects of TMP on H9c2 cells challenged with high glucose and those challenged with hypoxia show that TMP precisely regulated the hypoxic intensified apoptotic effects in high-glucose condition.The results clearly show that flavoring agent-TMP attenuates cytotoxicity amplified by hypoxia challenge in high glucose condition by destabilizing HIF-1α.CONCLUSIONThe results clearly show that flavoring agent-TMP attenuates cytotoxicity amplified by hypoxia challenge in high glucose condition by destabilizing HIF-1α.
ArticleNumber 12
Author Hsu, Yuan-Man
Huang, Chih-Yang
Wang, Shulin
Li, Qiaowen
Yang, Jai-Sing
Tsai, Chang-Hai
Shibu, Marthandam Asokan
Liu, Shih-Ping
Tsai, Fuu-Jen
Tang, Chih-Hsin
Chung, Jing-Gung
Author_xml – sequence: 1
  givenname: Shih-Ping
  surname: Liu
  fullname: Liu, Shih-Ping
– sequence: 2
  givenname: Marthandam Asokan
  surname: Shibu
  fullname: Shibu, Marthandam Asokan
– sequence: 3
  givenname: Fuu-Jen
  surname: Tsai
  fullname: Tsai, Fuu-Jen
– sequence: 4
  givenname: Yuan-Man
  surname: Hsu
  fullname: Hsu, Yuan-Man
– sequence: 5
  givenname: Chang-Hai
  surname: Tsai
  fullname: Tsai, Chang-Hai
– sequence: 6
  givenname: Jing-Gung
  surname: Chung
  fullname: Chung, Jing-Gung
– sequence: 7
  givenname: Jai-Sing
  surname: Yang
  fullname: Yang, Jai-Sing
– sequence: 8
  givenname: Chih-Hsin
  surname: Tang
  fullname: Tang, Chih-Hsin
– sequence: 9
  givenname: Shulin
  surname: Wang
  fullname: Wang, Shulin
– sequence: 10
  givenname: Qiaowen
  surname: Li
  fullname: Li, Qiaowen
– sequence: 11
  givenname: Chih-Yang
  surname: Huang
  fullname: Huang, Chih-Yang
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32021640$$D View this record in MEDLINE/PubMed
BookMark eNqNks1u1DAUhSNURH_gAdggS2zYBPybxBskqCgzUgUsytpynJuMR5442Mlowgux5kV4JjxMW7WVEGxsX_s7x7r2Oc2Oet9Dlj0n-DUhVfEmEiqrIscU55gzmu8eZSek5CwvcSmO7qyPs9MY1xgzxiV-kh0ziikpOD7JflzBGPQGxtXshjno77YHFGALIUJEK9ut8s5NxkdAtm8mAw1azYPfWYOgbcGMEdUz6qHTo92Cm5O2m1wq-g4tlhc5-fXzVvj-0_ILQ7AbAsRofY9Gj9LVzvqgR0ALaSgyOjTWb2ZfOx1HpAc_jD7a-DR73GoX4dn1fJZ9vfhwdb7ILz9_XJ6_u8yNEHLMta6MbAVvcG0oA6pZo8u6loy0vGq5xmmUkjeV0KIxzBSUixYqWhNWsKZh7CxbHnwbr9dqCHajw6y8turPhg-d0mG0xoEyNZRcc14awJwwU_EasMZFretSamyS19uD1zDVG2gM9Omp3T3T-ye9XanOb1UhpaC4TAavrg2C_zZBHNXGRgPO6R78FBUVlFMhBC3-jXKMeSEE-w-UCcKropJ79OUDdO2n0KcP2FMlr1KiZKJe3O3ztsGblCWgPAAm-BgDtMrYMWXE79u2ThGs9nlWhzyrlGe1z7PaJSV5oLwx_7vmN53C_IY
CitedBy_id crossref_primary_10_1002_tox_24372
crossref_primary_10_1007_s10522_021_09929_8
crossref_primary_10_3390_life12081250
crossref_primary_10_1016_j_jep_2020_113297
crossref_primary_10_1002_tox_23449
crossref_primary_10_3390_nu13061881
crossref_primary_10_18632_aging_205026
crossref_primary_10_3920_BM2020_0094
crossref_primary_10_1002_jcb_30146
crossref_primary_10_3390_ijms22126251
crossref_primary_10_1007_s12640_023_00666_z
crossref_primary_10_1016_j_fct_2020_111837
crossref_primary_10_1002_ptr_7855
crossref_primary_10_18632_aging_204210
crossref_primary_10_1002_tox_23450
crossref_primary_10_1002_tox_24385
crossref_primary_10_1007_s12602_020_09668_1
crossref_primary_10_1007_s13273_022_00250_0
crossref_primary_10_62347_XTRT2780
crossref_primary_10_18632_aging_204466
crossref_primary_10_1002_tox_23737
crossref_primary_10_1016_j_cbi_2020_109331
crossref_primary_10_1007_s13273_024_00464_4
crossref_primary_10_1016_j_cbi_2023_110451
crossref_primary_10_1016_j_jnutbio_2024_109567
crossref_primary_10_1002_tox_23385
crossref_primary_10_1002_tox_23660
crossref_primary_10_1002_tox_23544
crossref_primary_10_1016_j_freeradbiomed_2021_07_026
crossref_primary_10_1016_j_heliyon_2023_e20011
crossref_primary_10_1002_tox_23145
crossref_primary_10_1016_j_phymed_2020_153450
crossref_primary_10_1016_j_bbrc_2020_07_052
crossref_primary_10_3389_fnut_2023_1085248
crossref_primary_10_1016_j_jff_2023_105901
crossref_primary_10_1002_tox_24240
crossref_primary_10_3389_fcvm_2021_749072
crossref_primary_10_4103_cjop_CJOP_D_23_00009
crossref_primary_10_1002_tox_23153
crossref_primary_10_1002_bab_2620
crossref_primary_10_3389_fmed_2022_910623
crossref_primary_10_1002_tox_23553
crossref_primary_10_1016_j_biopha_2022_113005
crossref_primary_10_1002_tox_23717
crossref_primary_10_1016_j_crtox_2023_100136
crossref_primary_10_1017_S0031182022001408
crossref_primary_10_1007_s12640_022_00544_0
crossref_primary_10_1002_jcb_29946
crossref_primary_10_1007_s12013_022_01080_6
crossref_primary_10_1016_j_bcp_2024_116552
crossref_primary_10_1210_clinem_dgac378
crossref_primary_10_3390_molecules26216577
crossref_primary_10_1016_j_jff_2023_105874
crossref_primary_10_3390_ijms23031387
crossref_primary_10_1002_tox_23360
crossref_primary_10_1002_tox_24332
crossref_primary_10_1097_HJH_0000000000003285
crossref_primary_10_3389_fphar_2022_891729
crossref_primary_10_1002_tox_23880
crossref_primary_10_1016_j_heliyon_2024_e29729
crossref_primary_10_1002_tox_23521
crossref_primary_10_1016_j_prmcm_2022_100171
crossref_primary_10_18632_aging_204131
crossref_primary_10_1142_S0192415X22500549
crossref_primary_10_1016_j_biopha_2023_114294
crossref_primary_10_1016_j_biopha_2021_112427
crossref_primary_10_1007_s11010_021_04261_8
crossref_primary_10_1016_j_cbi_2022_109810
crossref_primary_10_1002_tox_23936
crossref_primary_10_1002_tox_23935
crossref_primary_10_1002_tox_23818
crossref_primary_10_1007_s11033_023_08327_2
crossref_primary_10_18632_aging_205230
crossref_primary_10_1021_acs_jafc_1c02384
crossref_primary_10_1142_S0192415X24500472
crossref_primary_10_1016_j_jare_2020_06_015
crossref_primary_10_1002_tox_23460
crossref_primary_10_2174_1381612829666230215100507
crossref_primary_10_1002_tox_23101
crossref_primary_10_1002_bab_2671
crossref_primary_10_3390_molecules27134106
crossref_primary_10_1007_s12013_024_01286_w
crossref_primary_10_1021_acs_jafc_4c05945
crossref_primary_10_1016_j_jff_2020_104255
crossref_primary_10_3389_fphar_2022_953438
crossref_primary_10_1016_j_mito_2024_101923
crossref_primary_10_1016_j_celbio_2025_100016
crossref_primary_10_18632_aging_205287
crossref_primary_10_1002_tox_23075
crossref_primary_10_1016_j_phymed_2022_154250
crossref_primary_10_1111_jfbc_14041
crossref_primary_10_1002_tox_23638
crossref_primary_10_1096_fj_202100572R
crossref_primary_10_1002_tox_23637
crossref_primary_10_1007_s12602_022_09982_w
crossref_primary_10_18632_aging_204526
crossref_primary_10_1039_D3DT02358C
Cites_doi 10.1001/archinte.163.4.445
10.1161/CIRCRESAHA.118.311371
10.1016/j.jvs.2010.12.030
10.2337/diaspect.21.3.160
10.1038/sj.cdd.4400852
10.1051/bmdcn/2017070204
10.4161/auto.5901
10.1016/j.jff.2018.10.038
10.1124/mol.106.027029
10.1002/tox.22510
10.1016/j.cub.2006.10.053
10.1242/jeb.01109
10.1016/j.jff.2018.11.040
10.1016/j.canlet.2013.03.015
10.1080/08977194.2016.1191480
10.1016/j.jep.2016.07.018
10.1016/j.vascn.2007.09.001
10.1080/09540105.2019.1611745
10.1016/j.ijcard.2015.05.111
10.1002/jcp.28151
10.1016/j.jnutbio.2015.12.020
10.1016/j.ejphar.2015.04.041
10.1007/s10616-016-9957-2
10.1371/journal.pone.0158619
10.1038/nature06639
10.1002/tox.22270
10.1016/j.neuropharm.2010.12.002
10.1056/NEJM200003023420904
10.1161/01.CIR.81.4.1161
10.1002/jms.3034
10.1084/jem.20030613
10.1186/s12986-019-0356-5
10.1007/s00204-015-1600-z
10.3390/nu5103854
10.4161/auto.5905
10.1038/sj.onc.1206666
10.1002/tox.22589
10.1007/978-981-10-5978-0_11
10.1161/CIRCRESAHA.107.164731
10.1016/j.molmed.2009.01.002
10.2337/diabetes.51.6.1938
10.1038/onc.2009.49
10.1002/tox.22742
10.1111/j.1742-7843.2007.00059.x
10.1007/s11626-010-9368-1
10.1007/s11010-008-9708-6
10.1016/S0008-6363(99)00372-7
10.1159/000374076
10.1038/nrc704
10.1161/01.CIR.0000091257.27563.32
10.1016/j.biopha.2017.11.020
10.1016/j.fct.2016.12.017
10.1101/gad.1243304
ContentType Journal Article
Copyright The Author(s). 2020.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s). 2020
Copyright_xml – notice: The Author(s). 2020.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s). 2020
DBID AAYXX
CITATION
NPM
3V.
7QP
7RV
7TS
7X7
7XB
88E
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
KB0
M0S
M1P
M2O
MBDVC
NAPCQ
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
7S9
L.6
5PM
DOA
DOI 10.1186/s12986-020-0432-x
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Nursing & Allied Health Database
Physical Education Index
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database ProQuest
Research Library
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Central China
Physical Education Index
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList Publicly Available Content Database
AGRICOLA
PubMed
AGRICOLA

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Diet & Clinical Nutrition
EISSN 1743-7075
EndPage 12
ExternalDocumentID oai_doaj_org_article_cbe74a447ce0413c84be0a06bab79a0c
PMC6995207
32021640
10_1186_s12986_020_0432_x
Genre Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GrantInformation_xml – fundername: ;
  grantid: CMU102-TC-01
GroupedDBID ---
04C
0R~
123
29N
2WC
53G
5VS
7RV
7X7
88E
8FI
8FJ
8G5
A8Z
AAFWJ
AAHBH
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
AZQEC
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BKEYQ
BMC
BMSDO
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
DWQXO
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EIHBH
EMB
EMK
EMOBN
ESTFP
ESX
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HH5
HMCUK
HYE
IAO
ICU
IHR
ISR
ITC
KQ8
M1P
M2O
M48
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SCM
SOJ
SV3
TUS
UKHRP
WOQ
WOW
XSB
2VQ
4.4
ADRAZ
AHSBF
C1A
EJD
EX3
H13
IPNFZ
NPM
PJZUB
PPXIY
RIG
3V.
7QP
7TS
7XB
8FK
K9.
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
7S9
L.6
5PM
PUEGO
ID FETCH-LOGICAL-c559t-aa8c9f54d0bc23e2a3da7bb931f48f4a048f994d85a5dc3c6245fe82b1363dd33
IEDL.DBID 7X7
ISSN 1743-7075
IngestDate Wed Aug 27 01:21:02 EDT 2025
Thu Aug 21 13:49:43 EDT 2025
Fri Jul 11 15:09:43 EDT 2025
Fri Jul 11 10:23:16 EDT 2025
Fri Jul 11 06:57:56 EDT 2025
Fri Jul 25 22:16:55 EDT 2025
Mon Jul 21 06:04:04 EDT 2025
Tue Jul 01 02:17:43 EDT 2025
Thu Apr 24 23:09:17 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Caspase
HIF-1
Hypoxia
Diabetes mellitus
Food flavoring
Language English
License The Author(s). 2020.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c559t-aa8c9f54d0bc23e2a3da7bb931f48f4a048f994d85a5dc3c6245fe82b1363dd33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/2357480339?pq-origsite=%requestingapplication%
PMID 32021640
PQID 2357480339
PQPubID 24069
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_cbe74a447ce0413c84be0a06bab79a0c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6995207
proquest_miscellaneous_2524255526
proquest_miscellaneous_2400465536
proquest_miscellaneous_2351486896
proquest_journals_2357480339
pubmed_primary_32021640
crossref_citationtrail_10_1186_s12986_020_0432_x
crossref_primary_10_1186_s12986_020_0432_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-01-31
PublicationDateYYYYMMDD 2020-01-31
PublicationDate_xml – month: 01
  year: 2020
  text: 2020-01-31
  day: 31
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Nutrition & metabolism
PublicationTitleAlternate Nutr Metab (Lond)
PublicationYear 2020
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References GZ Feuerstein (432_CR5) 2000; 45
E Magi (432_CR52) 2012; 47
M Hu (432_CR7) 2016; 2016
YF Chen (432_CR44) 2016; 31
S-C Liu (432_CR38) 2019; 30
AL Harris (432_CR11) 2002; 2
BB Dokken (432_CR6) 2008; 21
P Witek (432_CR20) 2016; 68
CC Feng (432_CR18) 2016; 34
N Yurkova (432_CR17) 2008; 102
N Mizushima (432_CR33) 2008; 451
YL Hsieh (432_CR42) 2016; 192
M Li (432_CR58) 2004; 31
HP Chen (432_CR55) 2007; 100
C-C Feng (432_CR26) 2016; 34
DL Pucciarelli (432_CR51) 2013; 5
CY Tsai (432_CR45) 2015; 195
S Kothari (432_CR14) 2003; 22
RM Graham (432_CR10) 2004; 207
JY Kim (432_CR12) 2004; 199
SH Lee (432_CR27) 2000; 342
J Chen (432_CR53) 2017; 109
RJ Thomas (432_CR2) 2003; 163
HC Kenny (432_CR3) 2019; 124
Y Zhang (432_CR8) 2018; 2018
K Sada (432_CR9) 2016; 11
W Bursch (432_CR35) 2001; 8
MA Shibu (432_CR48) 2017
RW Li (432_CR59) 2015; 761
C Mammucari (432_CR16) 2008; 4
TC Or (432_CR22) 2011; 60
L Fan (432_CR23) 2011; 54
X Gong (432_CR56) 2016; 90
H-P Lee (432_CR40) 2019; 52
L Cai (432_CR4) 2002; 51
CY Tsai (432_CR41) 2019; 34
RC Scott (432_CR34) 2007; 17
C-C Feng (432_CR25) 2018; 97
X Zhang (432_CR57) 2019; 234
K-H Lin (432_CR24) 2015; 36
M Asokan Shibu (432_CR47) 2017; 7
MA Shibu (432_CR46) 2018; 33
JM Hwang (432_CR29) 2008; 311
SJ Watkins (432_CR19) 2011; 47
CC Lin (432_CR39) 2019; 43
Q Ke (432_CR32) 2006; 70
J Shaw (432_CR13) 2008; 4
YC Hsieh (432_CR36) 2009; 15
KM Wu (432_CR37) 2019; 16
AV Kuznetsov (432_CR21) 1853; 2015
MA Pfeffer (432_CR28) 1990; 81
AJ Giaccia (432_CR31) 2004; 18
K-H Lin (432_CR50) 2019; 52
Z Chen (432_CR54) 2013; 336
G Chinnadurai (432_CR15) 2008; 27
MA Creager (432_CR1) 2003; 108
PY Chen (432_CR43) 2017; 32
JT Chiang (432_CR49) 2018; 33
KR Pitts (432_CR30) 2008; 57
References_xml – volume: 163
  start-page: 445
  year: 2003
  ident: 432_CR2
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.163.4.445
– volume: 124
  start-page: 121
  year: 2019
  ident: 432_CR3
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.118.311371
– volume: 54
  start-page: 192
  year: 2011
  ident: 432_CR23
  publication-title: J Vasc Surg
  doi: 10.1016/j.jvs.2010.12.030
– volume: 21
  start-page: 160
  year: 2008
  ident: 432_CR6
  publication-title: Diabetes Spectrum
  doi: 10.2337/diaspect.21.3.160
– volume: 8
  start-page: 569
  year: 2001
  ident: 432_CR35
  publication-title: Cell Death Differ
  doi: 10.1038/sj.cdd.4400852
– volume: 7
  start-page: 11
  year: 2017
  ident: 432_CR47
  publication-title: BioMedicine
  doi: 10.1051/bmdcn/2017070204
– volume: 4
  start-page: 427
  year: 2008
  ident: 432_CR13
  publication-title: Autophagy
  doi: 10.4161/auto.5901
– volume: 52
  start-page: 212
  year: 2019
  ident: 432_CR50
  publication-title: J Funct Foods
  doi: 10.1016/j.jff.2018.10.038
– volume: 70
  start-page: 1469
  year: 2006
  ident: 432_CR32
  publication-title: Mol Pharmacol
  doi: 10.1124/mol.106.027029
– volume: 33
  start-page: 220
  year: 2018
  ident: 432_CR46
  publication-title: Environ Toxicol
  doi: 10.1002/tox.22510
– volume: 2016
  start-page: 9
  year: 2016
  ident: 432_CR7
  publication-title: J Diab Res
– volume: 17
  start-page: 1
  year: 2007
  ident: 432_CR34
  publication-title: Curr Biol
  doi: 10.1016/j.cub.2006.10.053
– volume: 207
  start-page: 3189
  year: 2004
  ident: 432_CR10
  publication-title: J Exp Biol
  doi: 10.1242/jeb.01109
– volume: 52
  start-page: 537
  year: 2019
  ident: 432_CR40
  publication-title: J Funct Foods
  doi: 10.1016/j.jff.2018.11.040
– volume: 336
  start-page: 281
  year: 2013
  ident: 432_CR54
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2013.03.015
– volume: 43
  start-page: e12902
  year: 2019
  ident: 432_CR39
  publication-title: J Food Biochem
– volume: 34
  start-page: 73
  year: 2016
  ident: 432_CR18
  publication-title: Growth Factors
  doi: 10.1080/08977194.2016.1191480
– volume: 192
  start-page: 170
  year: 2016
  ident: 432_CR42
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2016.07.018
– volume: 34
  start-page: 73
  year: 2016
  ident: 432_CR26
  publication-title: Growth Factors
  doi: 10.1080/08977194.2016.1191480
– volume: 57
  start-page: 42
  year: 2008
  ident: 432_CR30
  publication-title: J Pharmacol Toxicol Methods
  doi: 10.1016/j.vascn.2007.09.001
– volume: 30
  start-page: 620
  year: 2019
  ident: 432_CR38
  publication-title: Food Agric Immunol
  doi: 10.1080/09540105.2019.1611745
– volume: 195
  start-page: 300
  year: 2015
  ident: 432_CR45
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2015.05.111
– volume: 234
  start-page: 15098
  year: 2019
  ident: 432_CR57
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.28151
– volume: 31
  start-page: 98
  year: 2016
  ident: 432_CR44
  publication-title: J Nutr Biochem
  doi: 10.1016/j.jnutbio.2015.12.020
– volume: 31
  start-page: 97
  year: 2004
  ident: 432_CR58
  publication-title: Clin Hemorheol Microcirc
– volume: 761
  start-page: 153
  year: 2015
  ident: 432_CR59
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2015.04.041
– volume: 68
  start-page: 2407
  year: 2016
  ident: 432_CR20
  publication-title: Cytotechnology
  doi: 10.1007/s10616-016-9957-2
– volume: 11
  start-page: e0158619
  year: 2016
  ident: 432_CR9
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0158619
– volume: 451
  start-page: 1069
  year: 2008
  ident: 432_CR33
  publication-title: Nature
  doi: 10.1038/nature06639
– volume: 2015
  start-page: 276
  year: 1853
  ident: 432_CR21
  publication-title: Biochim Biophys Acta
– volume: 32
  start-page: 679
  year: 2017
  ident: 432_CR43
  publication-title: Environ Toxicol
  doi: 10.1002/tox.22270
– volume: 60
  start-page: 823
  year: 2011
  ident: 432_CR22
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2010.12.002
– volume: 342
  start-page: 626
  year: 2000
  ident: 432_CR27
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200003023420904
– volume: 81
  start-page: 1161
  year: 1990
  ident: 432_CR28
  publication-title: Circulation
  doi: 10.1161/01.CIR.81.4.1161
– volume: 47
  start-page: 1191
  year: 2012
  ident: 432_CR52
  publication-title: J Mass Spectrom
  doi: 10.1002/jms.3034
– volume: 199
  start-page: 113
  year: 2004
  ident: 432_CR12
  publication-title: J Exp Med
  doi: 10.1084/jem.20030613
– volume: 16
  start-page: 36
  year: 2019
  ident: 432_CR37
  publication-title: Nutr Metab (Lond)
  doi: 10.1186/s12986-019-0356-5
– volume: 90
  start-page: 2187
  year: 2016
  ident: 432_CR56
  publication-title: Arch Toxicol
  doi: 10.1007/s00204-015-1600-z
– volume: 5
  start-page: 3854
  year: 2013
  ident: 432_CR51
  publication-title: Nutrients
  doi: 10.3390/nu5103854
– volume: 4
  start-page: 524
  year: 2008
  ident: 432_CR16
  publication-title: Autophagy
  doi: 10.4161/auto.5905
– volume: 22
  start-page: 4734
  year: 2003
  ident: 432_CR14
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1206666
– volume: 33
  start-page: 1113
  year: 2018
  ident: 432_CR49
  publication-title: Environ Toxicol
  doi: 10.1002/tox.22589
– start-page: 337
  volume-title: Medicinal Plants and Fungi: Recent Advances in Research and Development
  year: 2017
  ident: 432_CR48
  doi: 10.1007/978-981-10-5978-0_11
– volume: 102
  start-page: 472
  year: 2008
  ident: 432_CR17
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.107.164731
– volume: 2018
  start-page: 8
  year: 2018
  ident: 432_CR8
  publication-title: J Diab Res
– volume: 15
  start-page: 129
  year: 2009
  ident: 432_CR36
  publication-title: Trends Mol Med
  doi: 10.1016/j.molmed.2009.01.002
– volume: 51
  start-page: 1938
  year: 2002
  ident: 432_CR4
  publication-title: Diabetes
  doi: 10.2337/diabetes.51.6.1938
– volume: 27
  start-page: S114
  issue: Suppl 1
  year: 2008
  ident: 432_CR15
  publication-title: Oncogene
  doi: 10.1038/onc.2009.49
– volume: 34
  start-page: 760
  year: 2019
  ident: 432_CR41
  publication-title: Environ Toxicol
  doi: 10.1002/tox.22742
– volume: 100
  start-page: 366
  year: 2007
  ident: 432_CR55
  publication-title: Basic Clin Pharmacol Toxicol
  doi: 10.1111/j.1742-7843.2007.00059.x
– volume: 47
  start-page: 125
  year: 2011
  ident: 432_CR19
  publication-title: In Vitro Cell Dev Biol Anim
  doi: 10.1007/s11626-010-9368-1
– volume: 311
  start-page: 179
  year: 2008
  ident: 432_CR29
  publication-title: Mol Cell Biochem
  doi: 10.1007/s11010-008-9708-6
– volume: 45
  start-page: 560
  year: 2000
  ident: 432_CR5
  publication-title: Cardiovasc Res
  doi: 10.1016/S0008-6363(99)00372-7
– volume: 36
  start-page: 334
  year: 2015
  ident: 432_CR24
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000374076
– volume: 2
  start-page: 38
  year: 2002
  ident: 432_CR11
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc704
– volume: 108
  start-page: 1527
  year: 2003
  ident: 432_CR1
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000091257.27563.32
– volume: 97
  start-page: 880
  year: 2018
  ident: 432_CR25
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2017.11.020
– volume: 109
  start-page: 930
  year: 2017
  ident: 432_CR53
  publication-title: Food Chem Toxicol
  doi: 10.1016/j.fct.2016.12.017
– volume: 18
  start-page: 2183
  year: 2004
  ident: 432_CR31
  publication-title: Genes Dev
  doi: 10.1101/gad.1243304
SSID ssj0033490
Score 2.541332
Snippet Diabetic patients are highly vulnerable to hypoxic injury, which is associated with hypoxia induced BNIP3 expression that subsequently activate apoptosis. Our...
Background Diabetic patients are highly vulnerable to hypoxic injury, which is associated with hypoxia induced BNIP3 expression that subsequently activate...
BACKGROUND: Diabetic patients are highly vulnerable to hypoxic injury, which is associated with hypoxia induced BNIP3 expression that subsequently activate...
Abstract Background Diabetic patients are highly vulnerable to hypoxic injury, which is associated with hypoxia induced BNIP3 expression that subsequently...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 12
SubjectTerms Apoptosis
BNIP3 protein
Cardiomyocytes
Cardiovascular disease
Caspase
Cell viability
Cytotoxicity
Diabetes
Diabetes mellitus
Flavors
Food flavoring
Gene expression
Glucose
HIF-1
Hyperglycemia
Hypoxia
hypoxia-inducible factor 1
Membranes
Metabolism
nutrition
patients
protein synthesis
Proteins
pyrazines
SummonAdditionalLinks – databaseName: Directory of Open Access Journals (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtQwFLVQV2wQtDwCBRkJsUCKmsTvZQuMpkiMWLRSd5FfoSNNk6iTSpMvYs2P8E1cO8mog9CwYRtfJ7Hv9X3EJ8cIvXNccFpxm8rK6ZRSz1PjKE0tNV4L5vOKhZ-Tvy74_JJ-uWJX9476CpiwgR54mLgTa7ygmlJhfQYO10q4SaYzbrQRSmc2eF-IeVMxNfhgQqia9jBzyU_WENVkANsGKCMp0s1OFIpk_X_LMP8ESt6LPLPH6NGYMuLT4VWfoAe-PkRHpzWUyzc9fo8jiDN-HT9Eyael7-DaSPe5wouJbf8I_bjwXYBigWpWbX8beaVxYHAKMA4ceIsnADuGQh1U7vB13zabpcUj6gObHtf-e-QKX_XQN55jD8EPz89naf7r57bj2eL8G8F-M8Jsa9w1GB69CoQAncdzZQtsIxT2pm8MZPAd1m3Tds16uX6KLmefLz7O0_GchtRCPdKlWkurKkZdZmxBfKGJ08IYRfKKyopqcBKVUtRJppmzxPKCssrLwuSEE-cIeYYO6qb2LxB2QnNuiRAWOgqV60KawPDGaKUc9zJB2aS30o4k5uEsjVUZixnJy0HVJai6DKouNwn6sO3SDgwe-4TPgjFsBQP5drwAJlmOJln-yyQTdDyZUjl6hHUZaIWoBMtUCXq7bYa1HDZodO2buygD1SmXiu-RCU4XZoTsk2GhkGSsAJnngwVvR0QKyOo4zRIkdmx7Z8i7LfXyOvKOc6VYkYmX_2OOXqGHRVyOOWQBx-igu73zryG968ybuJJ_A404VHA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtNAEF5V5cIFQctPSkGLhDggGWzv_wGhFohSpEYcGqk3a3e9biO5dkhcKX4izrwIz8TsxrYIinK1Z2StZ2Znxvv5G4Te5lxwWnAbySLXEaWORyanNLLUOC2YSwrmf06-nPLJjH6_ZtcHqB9v1b3A1c7Wzs-Tmi3LD-uf7WcI-E8h4CX_uIKcJT2U1gMVSRpBSfkAEpPwAw0u6XCoQAhV_cHmTrWt1BQY_HeVnf-jJ_9JR-PH6FFXR-KzjeGfoANXHaHjswp66LsWv8MB2Rk-mR-h0de5a-BaxwFa4mlPwX-Mfl25xuOzwF7lol0GsmnsaZ08tgN7MuMe1Y6hewc_yPFtu6jXc4s7KAg2La7cTSAQL1vQDcPtISPiycU4Sv78HhTPpxc_CHbrDntb4abG8OjSswQ0Dk-UTbEN-Ni7tjZQ1jdYL-pFU6_mq6doNv529WUSdcMbIgtNShNpLa0qGM1jY1PiUk1yLYxRJCmoLKiGnaNQiuaSaZZbYnlKWeFkahLCSZ4T8gwdVnXlXiCcC825JUJYUBQq0ak0nvaN0ULl3MkRinu7ZbZjNvcDNsosdDiSZxtTZ2DqzJs6W4_Q-0FlsaH12Cd87p1hEPSM3OFCvbzJugDPrHGCakqFdTEUBlaCs8c65kYboXRsR-i0d6Ws9_LMcw1RCZ6pRujNcBsC3J_a6MrV90EGWlYuFd8j43dieCNknwzz3SVjKcg833jwsCKSQqnHaTxCYsu3t5a8faea3wYycq4US2Nxsn95L9HDNARaAkn_FB02y3v3Cqq5xrwOMfoXZbxOIg
  priority: 102
  providerName: Scholars Portal
Title Tetramethylpyrazine reverses high-glucose induced hypoxic effects by negatively regulating HIF-1α induced BNIP3 expression to ameliorate H9c2 cardiomyoblast apoptosis
URI https://www.ncbi.nlm.nih.gov/pubmed/32021640
https://www.proquest.com/docview/2357480339
https://www.proquest.com/docview/2351486896
https://www.proquest.com/docview/2400465536
https://www.proquest.com/docview/2524255526
https://pubmed.ncbi.nlm.nih.gov/PMC6995207
https://doaj.org/article/cbe74a447ce0413c84be0a06bab79a0c
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9RAFB60ffFFtPUSrcsI4oMQmmTuT9LVLluhS5EW-hbmlnZhm6S7KWx-kc_-EX-TM7NJdEX2JQ_JGcLknDmXmS_fAeCDoYziguqYF0bGGFsaK4NxrLGykhGbFsT_nHw-o9Mr_O2aXHcbbqsOVtn7xOCoTaX9Hvmxp2XBPEFIfK7vY981yp-udi00HoN9T13mrZpdDwUXQlj0J5kpp8crF9u4h9x6QCPK4vVWLAqU_f_LM_-FS_4VfybPwNMucYQnG00_B49seQAOT0pXNN-18CMMUM6wR34Aoq9z27h7HennAs56zv1D8OPSNh6Q5RS0qNtlYJeGnsfJgzmgZy_uYezQletO8QbetnW1nmvYYT-gamFpbwJj-KJ1Y0M3excC4fRsEqe_fg4Dx7OzCwTtugPblrCpoHv1wtMCNBZOhc6gDoDYu7ZSLo9voKyruqlW89ULcDU5vfwyjbtuDbF2VUkTS8m1KAg2idIZsplERjKlBEoLzAssnasohMCGE0mMRppmmBSWZypFFBmD0EuwV1alfQ2gYZJSjRjTbiATqcy48jxvBBfCUMsjkPR6y3VHZe47aizyUNJwmm9UnTtV517V-ToCn4Yh9YbHY5fw2BvDIOgpuMONanmTdys618oyLDFm2iYuE9DcWXciE6qkYkImOgJHvSnlnV9Y5X-sOALvh8duRftjGlna6iHIuBqVckF3yHjX674I2iVDfDlJSOZkXm0seJgRylxuR3ESAbZl21tT3n5Szm8D-zgVgmQJe7N7em_BkywstNRF-SOw1ywf7DuXvjVqFNboCOyPT2cX30dhE8RdzzH_Dfu9Tlc
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbhMxFLWqsoANgpZHoICRgAXSqDO2x48FQi0lSmgbsUil7Aa_Jo2UzoRkKjJfxA6JH-GbsJ2ZQBDKrtuZa0XOPb6-1z5zLgCvDGWU5FRHPDcyIsTSSBlCIk2UlSy1SZ76j5PPB7R3QT6N0tEO-NF-C-NplW1MDIHalNqfkR96WRbCY4zF-9nXyHeN8rerbQuNFSxObf3NlWyLd_0T59_XCHU_Dj_0oqarQKRd9lxFUnIt8pSYWGmELZLYSKaUwElOeE6kg3QuBDE8lanRWFNE0txypBJMsTH-ANSF_Ftu4419scdG6wIPYyLam9OE08OF20u5p_h6AiVG0XJj7wstAv6X1_5Lz_xrv-veA3ebRBUerZB1H-zYYg_sHxWuSL-q4RsYqKPhTH4PdE4mtnLPGpHRKRy0Gv_74PvQVp4A5gAxndXzoGYNvW6UJ49Ar5bc0ubhpDAOaAZe1rNyOdGw4ZpAVcPCjoNC-bR2Y8eh5Vgxhr1-N0p-_VwPPB70P2Nolw25t4BVCd1PT70MQWVhT2gEdSDgXtWlcnVDBeWsnFXlYrJ4AC5uxI8PwW5RFvYxgIZJSjVmTLuBTCQSceV15VKSC0Mt74C49VumG-l038FjmoUSitNs5erMuTrzrs6WHfB2PWS20g3ZZnzswbA29JLf4UE5H2dNBMm0soxIQpi2scs8NHerKZYxVVIxIWPdAQctlLImDi2yP6umA16uX7sI4q-FZGHL62DjamLKBd1i40O9-0fwNpvUl69pipzNoxWC1zPCyOWSlMQdwDawvTHlzTfF5DKonVMhUhSzJ9un9wLc7g3Pz7Kz_uD0KbiDwqJLXIZxAHar-bV95lLHSj0P6xWCLzcdIH4DXviIuQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tetramethylpyrazine+reverses+high-glucose+induced+hypoxic+effects+by+negatively+regulating+HIF-1%CE%B1+induced+BNIP3+expression+to+ameliorate+H9c2+cardiomyoblast+apoptosis&rft.jtitle=Nutrition+%26+metabolism&rft.date=2020-01-31&rft.pub=BioMed+Central&rft.eissn=1743-7075&rft.volume=17&rft.spage=1&rft_id=info:doi/10.1186%2Fs12986-020-0432-x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1743-7075&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1743-7075&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1743-7075&client=summon